A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Na√Øve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients